Vadastuximab Biosimilar – Anti-CD33, SIGLEC3 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameVadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade
SourceCAS 1436390-63-4
SpeciesChimeric
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsVadastuximab,h2H12ec,CD33, SIGLEC3,anti-CD33, SIGLEC3
ReferencePX-TA1420
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade

General information on Anti-CD33/SIGLEC3[Homo sapiens] (Vadastuximab) Monoclonal Antibody

Vadastuximab has been investigated for the treatment of Acute myeloid leukemia, Myelodysplastic Syndrome, Acute Myelogenous Leukemia, and Acute Promyelocytic Leukemia.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Vadastuximab Biosimilar – Anti-CD33, SIGLEC3 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD331 Recombinant Protein
Antigen

CD331 Recombinant Protein

PX-P4119 420€
Myeloid cell surface antigen CD33(CD33)
Antigen

Myeloid cell surface antigen CD33(CD33)

PX-P4861 210€
Sialic acid-binding Ig-like lectin 15(SIGLEC15)
Antigen

Sialic acid-binding Ig-like lectin 15(SIGLEC15)

PX-P4693 210€
CD333 / FGFR3, C-His, recombinant protein
Antigen

CD333 / FGFR3, C-His, recombinant protein

PX-P5614 420€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products